RudaCure has been selected for Incheon City's R&D Activation Project 'R&D Planning Consulting Support Project' for consulting on RCI002 (pain treatment).
Through this selection, the company will receive consulting support for the commercialization and IP protection of pain treatment RCI002 — currently in preparation for PCT and U.S. patent applications — as well as IP portfolio construction. This will serve as the basis for establishing its R&D strategy.